Alwin Köhler is the Scientific Director of the institute. He is Professor of Molecular Biology and appointed at both the University of Vienna and the Medical University of Vienna. His research covers many aspects of the cell nucleus, including the nuclear envelope, chromatin and nuclear pores.
Fabien Martins is the Administrative & Finance Director of the Max Perutz Labs. He works closely with our two stakeholders to ensure that we can operate under the best financial conditions conducive to our future growth and development.
The Scientific Advisory Board (SAB) is composed of internationally renowned scientists who regularly evaluate the quality of research at the Max Perutz Labs.
Dr. Arrowsmith is the director of the Toronto Node of the Structural Genomics Consortium (SGC), Senior Scientist at the Princess Margaret Cancer Centre, and Professor of Medical Biophysics at the University of Toronto. Dr. Arrowsmith is an internationally recognized expert in cancer related structural biology & chemical biology and epigenetics.
Dr. Dikic is Professor at the Goethe University in Frankfurt am Main and director of the Institute of Biochemistry II. He is also the founding director of the Buchmann Institute for Molecular Life Sciences (BMLS), where he until today sustains an outstation lab.
Benjamin G. Neel is Professor at the Department of Medicine at the New York University, and the director of the Perlmutter Cancer Center, where he leads a rigorous academic community of clinician–scientists and basic scientists, as well as a team of physicians.
Professor Peter Parker is Deputy Director of the King's Health Partners Integrated Cancer Centre (ICC), Head of the Division of Cancer Studies at King's College London and co-director of the King’s College London Experimental Cancer Medicine Centre.